clonidine has been researched along with ascorbic acid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Guo, Y; Liu, J; Ma, X; Ma, Z; Ning, X; Tian, C; Wang, X; Zhang, Z; Zhu, R | 1 |
| Cheng, C; Du, Y; Guo, Y; Liu, J; Ma, X; Ma, Z; Ning, X; Shi, X; Tian, C; Wang, X; Zhang, Z; Zhu, R | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jiang, X; Liu, XH; Shi, J; Tang, W; Wang, S; Wu, C; Xu, Y; Zha, L; Zhang, J; Zhang, Z; Zuo, J | 1 |
| Lerer, B | 1 |
| Dollery, CT; Reid, JL | 1 |
| De Robertis, E; Levi de Stein, M; Wolfman, C | 1 |
| Kawai, M; Nomura, Y; Segawa, T | 1 |
| Balacco-Gabrieli, C; Giuliani, E; Latorre, M; Mastrandrea, G; Salamanna, S | 1 |
2 review(s) available for clonidine and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Alternative therapies for bipolar disorder.
Topics: Ascorbic Acid; Bipolar Disorder; Bupropion; Carbamazepine; Choline; Clonazepam; Clonidine; Clorgyline; Demeclocycline; Fenfluramine; Humans; Methylene Blue; Phosphatidylcholines; Physostigmine; Propiophenones; Propranolol; Spironolactone; Thyroxine; Tryptophan; Valproic Acid | 1985 |
10 other study(ies) available for clonidine and ascorbic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury.
Topics: Animals; Blood-Brain Barrier; Caffeic Acids; Cell Line, Tumor; Drug Design; Free Radical Scavengers; Mice; Microglia; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Phenylethyl Alcohol; Rats; Stereoisomerism; Sulfonamides | 2013 |
Design, synthesis, and biological evaluation of (e)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides as novel multifunctional neuroprotective agents.
Topics: Animals; Blood-Brain Barrier; Drug Design; Free Radical Scavengers; Humans; Neuroprotective Agents; Nitric Oxide; Oxidopamine; PC12 Cells; Rats; Sulfones; Sulfoxides | 2014 |
Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Binding Sites; Blood-Brain Barrier; Butyrylcholinesterase; Cannabidiol; Carbamates; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Drug Design; Humans; Kinetics; Maze Learning; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Neuroprotective Agents; Structure-Activity Relationship | 2021 |
Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit.
Topics: Animals; Ascorbic Acid; Blood Pressure; Brain Chemistry; Catheterization; Clonidine; Dose-Response Relationship, Drug; Fluorometry; Heart Atria; Heart Rate; Hydroxydopamines; Male; Neurons; Norepinephrine; Rabbits; Statistics as Topic; Time Factors | 1973 |
Time course of changes in [3H]prazosin binding after catecholaminergic denervation by 6-hydroxydopamine in rat cerebral cortex. Inhibitory effects of ascorbic acid on the alpha 1-adrenoceptor.
Topics: Animals; Ascorbic Acid; Brain; Catecholamines; Clonidine; Female; Hydroxydopamines; Kinetics; Male; Oxidopamine; Prazosin; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Sympathectomy, Chemical; Time Factors | 1983 |
The interaction between beta- and alpha 2-adrenoceptors in cerebral cortical membranes: isoproterenol-induced increase in [3H]clonidine binding in rats.
Topics: Animals; Ascorbic Acid; Cell Membrane; Cerebral Cortex; Clonidine; Dihydroalprenolol; Isoproterenol; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Temperature | 1984 |
[Changes in ocular tonus, pH and concentration of ascorbic acid and lactic acid in the aqueous humor of rabbits treated with clonidine].
Topics: Animals; Aqueous Humor; Ascorbic Acid; Clonidine; Hydrogen-Ion Concentration; Intraocular Pressure; Lactates; Rabbits; Tonometry, Ocular | 1983 |